Virtual Medicinal Product (VMP) - Bumetanide 500microgram / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Bumetanide 500microgram / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets Start Date 31-05-2005 End Date
Previous Name Previous Name Bumetanide 500microgram / Potassium 7.7mmol modified-release tablets Start Date 18-12-2002 End Date 30-05-2005
Abbreviated Name Abbreviated Name Bumetanide 500microg/Pot chlor 573mg (pot 7.7mmol) MR tab Start Date 01-05-2009
Previous Abbreviated Name Bumetanide 500microgram/Pot chlor 573mg(pot 7.7mmol)MR tabs Previous Start Date 31-05-2005 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Modified-release tablet
Ontology Form/Route
tabletmodified-release.oral
Non-availability Indicator
Actual Products not Available
Name Basis
Other

Codes

ATC Code
C03CB02
BNF Start Date End Date
Current BNF 02020800 Start Date 04-04-2022 End Date
Previous BNF 02020800 Start Date 01-02-2005 End Date 21-11-2007
SNOMED Codes
Code Start Date End Date
35913011000001100 19-10-2018
318165003 18-12-2002 18-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Bumetanide Based on Ingredient Substance 500 microgram
Potassium chloride Based on Ingredient Substance 573 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
28 tablet